title: Etanercept tolerance in a patient with previous infliximab-induced hepatitis.
authors.forename: Heidemarie
authors.initials: H
authors.lastname: Becker
authors.forename: Peter
authors.initials: P
authors.lastname: Willeke
authors.forename: Wolfram
authors.initials: W
authors.lastname: Domschke
authors.forename: Markus
authors.initials: M
authors.lastname: Gaubitz
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068800:Etanercept; D005260:Female; D019693:Hepatitis, Autoimmune / Q000209:etiology* / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology / Q000627:therapeutic use*; D000069285:Infliximab; D018124:Receptors, Tumor Necrosis Factor / Q000276:immunology / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept
references.citation: J Dermatolog Treat. 2005;16(5-6):347-9
references.pmid: 16428159
references.citation: Clin Rheumatol. 2007 Apr;26(4):578-81
references.pmid: 16547695
references.citation: Clin Rheumatol. 2008 Aug;27(8):1063-6
references.pmid: 18563514